Prof Ben Tran
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
467 Scholarly works
11 Projects
HIGHLIGHTS
2026
Journal article
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy from a First-in-Human Study of Volrustomig, a Novel PD-1/CTLA-4 Bispecific Antibody.
DOI: 10.1158/1078-0432.CCR-25-34472026
Journal article
Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinoma.
DOI: 10.1038/s41467-026-74255-x2026
Journal article
Advances in cancer immunotherapy: adoptive cell therapy and immune cell engagers in solid tumours
DOI: 10.1038/s41416-026-03450-w2026
Journal article
A simple plan: chemotherapy-sparing approaches to early-stage and regional seminoma and nonseminoma
DOI: 10.1016/j.annonc.2026.04.0052022
Research grants (ARC, NHMRC, MRFF)
Targeting Cold Tumours With Triple Therapy
2019
Research Grant
PRECEPT - PRostatE CancEr Prognosis and Treatment
2017
Research Grant
Combination of Radionuclide 177lu-Psma Therapy With Pembrolizumab in Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc)
RECENT SCHOLARLY WORKS
2026
Journal article
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials
DOI: 10.1016/j.eururo.2026.03.0242026
Journal article
The Australian Penile Cancer Clinical Registry: a comprehensive national approach to data collection
DOI: 10.1111/bju.701882026
Journal article
Prognostic Value of Restaging [18F]FDG PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Therapy.
DOI: 10.2967/jnumed.126.2725312026
Journal article
Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case Series
DOI: 10.1111/ajco.700832026
Journal article
XALience: A phase 3, open-label, multicenter, randomized study of xaluritamig plus abiraterone vs investigator’s choice in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer.
DOI: 10.1200/jco.2026.44.16_suppl.tps51442026
Journal article
IP13-16 ROBOTIC-ASSISTED RETROPERITONEAL LYMPH NODE DISSECTION FOR METASTATIC TESTICULAR MALIGNANCIES – A 9-YEAR COMPARATIVE ANALYSIS OF THE OUTCOMES AND LEARNING CURVE
DOI: 10.1097/01.ju.0001191348.53260.b7.16
RECENT PROJECTS
2024
Research grants (other domestic)
Stereotactic Ablative Body Radiotherapy (SABR) for 4 Gynaecologic Metastases
2024
Research grants (ARC, NHMRC, MRFF)
P3BEP Trial - Accelerating First-Line Chemotherapy to Improve Cure Rates for Advanced Germ Cell Tumours - An Australian-Led, International Randomised Trial